✦ LIBER ✦

PD-11.11: Phase II marker lesion study with intravesical instillation of Eoquin™ in superficial bladder cancer: toxicity, marker response and follow up

✍ Scribed by A.G. van der Heijden; K. Hendricksen; E.B. Cornel; H. Vergunst; T.M. de Reijke; E. van Boven; E.J. Barten; S. Chawla; G. Lenaz; J.A. Witjes

Book ID: 116946302
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 64 KB
Volume: 68
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2006.08.130

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PHASE II MARKER LESION STUDY WITH INTRAV

PHASE II MARKER LESION STUDY WITH INTRAVESICAL INSTILLATION OF EOQUIN TM IN SUPERFICIAL BLADDER CANCER, TOXICITY AND MARKER RESPONSE - THE FINAL RESULTS

✍ A.G. Van der Heijden; P.M.J. Moonen; E.B. Cornel; H. Vergunst; T.M. De Reijke; E 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 52 KB

873Phase 2 marker lesion study with intr

873Phase 2 marker lesion study with intravesical instillation of eoquin™ in superficial bladder cancer — Preliminary results of the marker response

✍ A. Van der Heijden; P. Moonen; T. De Reijke; E. Van Boven; H. Vergunst; E. Barte 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Two-year follow-up of the phase II marke

Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer

✍ Kees Hendricksen; Antoine G. van der Heijden; Erik B. Cornel; Henk Vergunst; The 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 286 KB

Phase II marker lesion study with intrav

Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response: van der Heijden AG, Moonen PM, Cornel EB, Vergunst H, de Reijke TM, van Boven E, Barten EJ, Puri R, van Kalken CK, Witjes JA, University Medical Centre Nijmegen, Nijmegen, The Netherlands

✍ H. Barton Grossman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB